Publicacions en col·laboració amb investigadors/es de Hospital Universitario La Paz (24)

2024

  1. Congestion as a crucial factor determining albuminuria in patients with cardiorenal disease

    Clinical Kidney Journal, Vol. 17, Núm. 6

2023

  1. Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus

    Journal of Clinical Medicine, Vol. 12, Núm. 1

  2. Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes

    Journal of Clinical Medicine, Vol. 12, Núm. 12

  3. Prevalence and clinical profile of kidney disease in patients with chronic heart failure. Insights from the Spanish cardiorenal registry

    Revista Espanola de Cardiologia

  4. Sex differences in Cardiorenal Syndrome: Insights from CARDIOREN Registry

    Current Heart Failure Reports, Vol. 20, Núm. 3, pp. 157-167

2022

  1. A practical approach to semaglutide use in patients with type-2 diabetes

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SD, pp. 1-9

  2. Evaluation of prophylaxis in primary prevention with acetylsalicylic acid in people with diabetes: A scoping review

    Semergen, Vol. 48, Núm. 4, pp. 275-292

2020

  1. Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease

    Clinical Kidney Journal, Vol. 13, Núm. 6, pp. 1017-1024

  2. Prevalence of vertebral fractures and their prognostic significance in the survival in patients with chronic kidney disease stages 3-5 not on dialysis

    Journal of Clinical Medicine, Vol. 9, Núm. 5, pp. 1-11

2019

  1. Association of candidate gene polymorphisms with chronic kidney disease: Results of a case-control analysis in the NEFRONA cohort

    Frontiers in Genetics, Vol. 10, Núm. FEB

  2. Comprehensive approach to the patient with diabetes mellitus and cardiovascular disease or very high cardiovascular risk

    REC: CardioClinics, Vol. 54, Núm. 3, pp. 183-192

2017

  1. Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: The NEFRONA study

    Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 513-520

2016

  1. Letter by Escobar et al Regarding Article, "on-Treatment Outcomes in Patients with Worsening Renal Function with Rivaroxaban Compared with Warfarin: Insights from ROCKET AF"

    Circulation

2015

  1. Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease

    Nephrology Dialysis Transplantation, Vol. 30, Núm. 7, pp. 1176-1185

2014

  1. Executive summary of the recommendations on the evaluation and management of renal disease in human immunodeficiency virus-infected patients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 32, Núm. 9, pp. 583-597

  2. Resumen ejecutivo del documento de consenso sobre el manejo de la patología renal en pacientes con infección por VIH

    Nefrologia, Vol. 34, Núm. 6, pp. 768-788

2011

  1. Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in spain: The MERENA observational cohort study

    BMC Nephrology, Vol. 12, Núm. 1

2009

  1. A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function

    Clinical Transplantation, Vol. 23, Núm. 1, pp. 23-32

  2. Anemia development and cardiovascular risk management in nonanemic stage 3 chronic kidney disease

    Renal Failure, Vol. 31, Núm. 10, pp. 869-875

2005

  1. Directrices y guías de consenso para el manejo de la nefropatía diabética: ¿Son realmente válidas?

    Nefrologia, Vol. 25, Núm. SUPPL.4, pp. 28-33